Switch theme
Sign up to access all valuation multiples
MediClin AG is a company engaged in operating hospitals. The operating segments of the group are Post-acute, Acute, and Other activities. The company generates the majority of its revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.
1996
9.6K+
LTM Revenue $812M
LTM EBITDA $112M
$510M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MediClin has a last 12-month revenue of $812M and a last 12-month EBITDA of $112M.
In the most recent fiscal year, MediClin achieved revenue of $784M and an EBITDA of $109M.
MediClin expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MediClin valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $757M | $784M | XXX | XXX | XXX |
| Gross Profit | $592M | $614M | XXX | XXX | XXX |
| Gross Margin | 78% | 78% | XXX | XXX | XXX |
| EBITDA | $98.6M | $109M | XXX | XXX | XXX |
| EBITDA Margin | 13% | 14% | XXX | XXX | XXX |
| Net Profit | $1.6M | $10.1M | XXX | XXX | XXX |
| Net Margin | 0% | 1% | XXX | XXX | XXX |
| Net Debt | n/a | $6.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MediClin's stock price is EUR 3 (or $3).
MediClin has current market cap of EUR 138M (or $148M), and EV of EUR 475M (or $510M).
See MediClin trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $510M | $148M | XXX | XXX | XXX | XXX | $0.59 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MediClin has market cap of $148M and EV of $510M.
MediClin's trades at 0.6x LTM EV/Revenue multiple, and 4.6x LTM EBITDA.
Analysts estimate MediClin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MediClin and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $510M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 4.7x | XXX | XXX | XXX |
| P/E | -12.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 11.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMediClin's NTM/LTM revenue growth is 3%
MediClin's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, MediClin's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MediClin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MediClin and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 17% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 80% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MediClin acquired XXX companies to date.
Last acquisition by MediClin was XXXXXXXX, XXXXX XXXXX XXXXXX . MediClin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MediClin founded? | MediClin was founded in 1996. |
| Where is MediClin headquartered? | MediClin is headquartered in Germany. |
| How many employees does MediClin have? | As of today, MediClin has 9.6K+ employees. |
| Is MediClin publicy listed? | Yes, MediClin is a public company listed on ETR. |
| What is the stock symbol of MediClin? | MediClin trades under MED ticker. |
| When did MediClin go public? | MediClin went public in 2000. |
| Who are competitors of MediClin? | Similar companies to MediClin include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of MediClin? | MediClin's current market cap is $148M |
| What is the current revenue of MediClin? | MediClin's last 12-month revenue is $812M. |
| What is the current EBITDA of MediClin? | MediClin's last 12-month EBITDA is $112M. |
| What is the current EV/Revenue multiple of MediClin? | Current revenue multiple of MediClin is 0.6x. |
| What is the current EV/EBITDA multiple of MediClin? | Current EBITDA multiple of MediClin is 4.6x. |
| What is the current revenue growth of MediClin? | MediClin revenue growth between 2023 and 2024 was 4%. |
| Is MediClin profitable? | Yes, MediClin is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
